Abstract
Treatment induced neuropathy of diabetes is a condition characterized by the acute development of painful small fiber neuropathy and autonomic dysfunction in the setting of rapid glycemic control. The prevalence is not known but was reported in 10% of cases studied in a specialized diabetic neuropathy tertiary referral center. Treatment induced neuropathy of diabetes is typically reported with the sudden decrease in the glycosylated hemoglobin A1C in individuals with a history of longstanding hyperglycemia. It is more common in individuals with type 1 diabetes, but has been reported with use of insulin, diet alone and with use of oral hypoglycemic medications. The onset of neuropathy is typically 2–8 weeks after a change in glucose control. Although the primary clinical phenotype is one of a length dependent, predominantly small fiber, neuropathic process, there is the frequent concordant development of autonomic dysfunction, retinopathy, and nephropathy. Treatment induced neuropathy of diabetes does not have any specific guidance on a treatment plan, supportive care is the recommended approach. It is possible that more gradual reduction in glucose control may prevent the development of treatment induced neuropathy, although prospective clinical trials to investigate this question have not been conducted.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gibbons CH, Freeman R. Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol. 2010;67:534–41.
Pomeranz B, Macaulay RJ, Caudill MA, et al. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151–3.
Ellenberg M. Diabetic neuropathic cachexia. Diabetes. 1974;23:418–23.
Archer AG, Watkins PJ, Thomas PK, Sharma AK, Payan J. The natural history of acute painful neuropathy in diabetes mellitus. J Neurol Neurosurg Psychiatry. 1983;46:491–9.
Neal JM. Diabetic neuropathic cachexia: a rare manifestation of diabetic neuropathy. South Med J. 2009;102:327–9.
Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2015;138:43–52.
Dyck PJ, Norell JE, Dyck PJ. Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology. 1999;53:2113–21.
Alexandrou EG, Corathers SD, Lahoti A, et al. Treatment-induced neuropathy of diabetes in youth: case series of a heterogeneous and challenging complication. J Endocr Soc. 2020;4(12):bvaa154.
Castellanos F, Mascias J, Zabala JA, Ricart C, Cabello A, Garcia-Merino A. Acute painful diabetic neuropathy following severe weight loss. Muscle Nerve. 1996;19:463–7.
Gibbons CH, Freeman R. Treatment-induced neuropathy of diabetes: an acute, iatrogenic complication of diabetes. Brain. 2014;138:43–52.
Gibbons CH. Treatment induced neuropathy of diabetes. Auton Neurosci. 2020;226:102668.
Group DR. Early worsening of diabetic retinopathy in the Diabetes Control and Complications Trial. Arch Ophthalmol. 1998;116:874–86.
Lim SW, van Wijngaarden P, Harper CA, Al-Qureshi SH. Early worsening of diabetic retinopathy due to intensive glycaemic control. Clin Experiment Ophthalmol. 2019;47:265–73.
Knopp M, Srikantha M, Rajabally YA. Insulin neuritis and diabetic cachectic neuropathy: a review. Curr Diabetes Rev. 2013;9:267–74.
Tesfaye S, Malik R, Harris N, et al. Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia. 1996;39:329–35.
Kihara M, Zollman PJ, Smithson IL, Lagerlund TD, Low PA. Hypoxic effect of exogenous insulin on normal and diabetic peripheral nerve. Am J Physiol. 1994;266:E980–5.
Gibbons CH, Adler GK, Bonyhay I, Freeman R. Experimental hypoglycemia is a human model of stress-induced hyperalgesia. Pain. 2012;153:2204–9.
Llewelyn JG, Thomas PK, Fonseca V, King RHM, Dandona P. Acute painful diabetic neuropathy precipitated by strict glycaemic control. Acta Neuropathol. 1986;72:157–63.
Llewelyn JG, Thomas P, Fonseca V, Dandona P. Acute painful diabetic neuropathy. Diabetes Care. 1988;11:748–9.
Nicodemus JM, Enriquez C, Marquez A, Anaya CJ, Jolivalt CG. Murine model and mechanisms of treatment-induced painful diabetic neuropathy. Neuroscience. 2017;354:136–45.
Lim SW, van Wijngaarden P, Harper CA, Al-Qureshi SH. Early worsening of diabetic retinopathy due to intensive glycaemic control. Clin Exp Ophthalmol. 2019;47:265–73.
Chantelau E, Meyer-Schwickerath R, Klabe K. Downregulation of serum IGF-1 for treatment of early worsening of diabetic retinopathy: a long-term follow-up of two cases. Ophthalmologica. 2010;224:243–6.
Davis MD, Beck RW, Home PD, Sandow J, Ferris FL. Early retinopathy progression in four randomized trials comparing insulin glargine and NPH insulin. Exp Clin Endocrinol Diabetes. 2007;115:240–3.
Chandler E, Brown M, Wintergerst K, Doll E. Treatment-induced neuropathy of diabetes (TIND) in pediatrics: a case report and review of the literature. J Clin Endocrinol Metabol. 2019;105:395–8.
Varadharaju N, Jeevarathnam D, Rajan M, Ponnurangam Nagarajan V, James S. A case of treatment-induced neuropathy in an adolescent with type 1 diabetes. Ann Pediatr Endocrinol Metab. 2019;24:203–6.
Gibbons CH, Goebel-Fabbri A. Microvascular complications associated with rapid improvements in glycemic control in diabetes. Curr Diab Rep. 2017;17:48.
Gibbons CH. Treatment induced neuropathy of diabetes-long term implications in type 1 diabetes. J Diabetes Complications. 2017;31(4):715–20.
Dabby R, Sadeh M, Lampl Y, Gilad R, Watemberg N. Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomed Pharmacother. 2009;63:707–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
McMillan, N., Gibbons, C.H. (2023). Treatment Induced Neuropathy of Diabetes. In: Tesfaye, S., Gibbons, C.H., Malik, R.A., Veves, A. (eds) Diabetic Neuropathy. Contemporary Diabetes. Humana, Cham. https://doi.org/10.1007/978-3-031-15613-7_9
Download citation
DOI: https://doi.org/10.1007/978-3-031-15613-7_9
Published:
Publisher Name: Humana, Cham
Print ISBN: 978-3-031-15612-0
Online ISBN: 978-3-031-15613-7
eBook Packages: MedicineMedicine (R0)